维普期刊资源整合服务平台（V6.5）

54篇 您的检索式：作者名="FILIPPATOS TD"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Ef- fects of plant sterols and stanols beyond low density lipoprotein cholesterol lowering 显示文摘	Derdemezis CS Filippatos TD Mikhailidis DP	2010	Cardiovasc Pharmacol Ther2010，，3：	1
2	Increased plasma visfatin levels in sujects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
3	Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Kiortsis DN	2007	J Endocrinol Invest2007，30，4：	1
4	Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2(Lp-PLA2)activity in heathy obese women显示文摘	Tzotzas L Filippatos TD Triantos	2008	Nutr Metab Car- diovasc Dis2008，18，7：	1
5	Increased plasma Visfatin levels in subjects with the metabolic syndrome 显示文摘	FILIPPATOS TD DERDEMEZIS CS GAZII F	2008	Eur J Clin Invest2008，38，1：	1
6	High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia显示文摘	Agouridis AP Tsimihodimos V Filippatos TD	2011	Lipids2011，46，6：	1
7	Excess body we-ight and risk of first-ever acute ischaemic non-embolic stroke in eld-erly subjects显示文摘	Milionis HJ Filippatos TD Derdemezis CS	2007	Eur J Neurol2007，14，7：	1
8	Increased plasma visfatin levels in subjects with the metabolic syndrome 显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Eur J Clin Invest2008，38，1：	1
9	Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile 显示文摘	FILIPPATOS TD TSIMIHODIMOS V DERDEMEZIS CS etal	2013	Nutr Metab Cardiovasc Dis2013，23，4：	1
10	Orlistat- associated adverse effects and drug interactions: a critical review 显示文摘	FILIPPATOS TD DERDEMEZIS CS GAZI IF	2008	DrugSaf2008，31，1：	1
11	Lipid-lowering drugs acting at the level of the gastrointestinal tract 显示文摘	Filippatos TD Mikhailidis DP	2009	Curr Pharm Des2009，15，5：	1
12	Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia显示文摘	Kostapanos MS Derdemezis CS Filippatos TD	2008	Eur J Pharmacol2008，578，23：	1
13	Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia 显示文摘	Kostapanos MS Derdemezis CS Filippatos TD	2008	Eur J Pharmacol2008，578，23：	1
14	Visfatin/PBEF and atherosclerosis-related diseases 显示文摘	Filippatos TD Randeva HS Derdemezis CS	2010	Curr Vasc Pharmacol2010，8，1：	1
15	Statins and Heart Failure 显示文摘	Filippatos TD Mikhailidis DP	2008	Angiology2008，59，2：	1
16	A-nalysis of 6-month effect of orlistat administration,aloneor incombination with fenofibrate,on triglyceride-rich lip-oprotein metabolism in overweight and obese patients withmetabolic syndrome显示文摘	Filippatos TD Tsimihodimos V Kostapanos M	2008	J Clin Lipidol2008，2，4：	1
17	Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia显示文摘	Filippatos TD Elisaf MS	2011	Expert Opinion on Pbarmacotherapy2011，12，12：	1
18	Orlistatassociated adverse effects and drug interactions显示文摘	Filippatos TD Derdemezis CS Gazi IF	2008	Drug Saf2008，31，1：	1
19	Increased plasma Visfatin levels in subjects with the metabolic syndrome显示文摘	Filippatos TD Derdemezis CS GaziIF		0，，01：	1
20	Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemia显示文摘	Kostapanos MS Derdemezis CS Filippatos TD		0，，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示